The source of cells for allografting

被引:9
作者
Couban, S
Barnett, M
机构
[1] Dalhousie Univ, Dept Med, Halifax, NS B3H 2Y9, Canada
[2] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Halifax, NS B3H 2Y9, Canada
[3] St Bartholomews Hosp, Dept Med Oncol, London, England
关键词
bone marrow transplantation; peripheral blood transplantation; allogeneic;
D O I
10.1016/j.bbmt.2003.08.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral blood is used almost exclusively as the source of hematopoietic cells for autografting, but the best source of cells for allografting is the subject of considerable discussion and debate. Randomized studies comparing unstimulated bone marrow with G-CSF-mobilized peripheral blood in the sibling allogeneic setting have indicated a trend to more chronic graft-versus-host disease in peripheral blood recipients. However, whether the use of G-CSF-mobilized peripheral blood cells leads to more acute graft-versus-host disease is uncertain. Adults undergoing sibling allografting appear to benefit in terms of improved disease-free survival or improved overall survival with the use of G-CSF-mobilized peripheral blood. It is not clear, however, whether these benefits also extend to children or those undergoing matched unrelated transplantation. (C) 2003 American Society for Blood and Marrow Transplantation
引用
收藏
页码:669 / 673
页数:5
相关论文
共 33 条
  • [1] Anderlini P, 1997, BLOOD, V90, P903
  • [2] Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals
    Anderlini, P
    Przepiorka, D
    Champlin, R
    Korbling, M
    [J]. BLOOD, 1996, 88 (08) : 2819 - 2825
  • [3] Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
    Arpinati, M
    Green, CL
    Heimfeld, S
    Heuser, JE
    Anasetti, C
    [J]. BLOOD, 2000, 95 (08) : 2484 - 2490
  • [4] Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45
  • [5] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
    Bensinger, WI
    Martin, PJ
    Storer, B
    Clift, R
    Forman, SJ
    Negrin, R
    Kashyap, A
    Flowers, MED
    Lilleby, K
    Chauncey, TR
    Storb, R
    Appelbaum, FR
    Rowley, S
    Heimfeld, S
    Blume, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) : 175 - 181
  • [6] TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
    BENSINGER, WI
    WEAVER, CH
    APPELBAUM, FR
    ROWLEY, S
    DEMIRER, T
    SANDERS, J
    STORB, R
    BUCKNER, CD
    [J]. BLOOD, 1995, 85 (06) : 1655 - 1658
  • [7] Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
    Blaise, D
    Kuentz, M
    Fortanier, C
    Bourhis, JH
    Milpied, N
    Sutton, L
    Jouet, JP
    Attal, M
    Bordigoni, P
    Cahn, JY
    Boiron, JM
    Schuller, MP
    Moatti, JP
    Michalle, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 537 - 546
  • [8] Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor
    Cavallaro, AM
    Lilleby, K
    Majolino, I
    Storb, R
    Appelbaum, FR
    Rowley, SD
    Bensinger, WI
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (01) : 85 - 89
  • [9] Champlin RE, 2000, BLOOD, V95, P3702
  • [10] Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: A study of 29 patients
    Couban, S
    Messner, HA
    Andreou, P
    Egan, B
    Price, S
    Tinker, L
    Meharchand, J
    Forrest, DL
    Lipton, J
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (4A) : 422 - 427